Corcept Therapeutics
CORT
CORT
59 hedge funds and large institutions have $161M invested in Corcept Therapeutics in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 49 → 59 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
59
Holding in Top 10
1
Calls
$2.64M
Puts
$233K
Top Buyers
| 1 | +$5.44M | |
| 2 | +$4.36M | |
| 3 | +$2.48M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.37M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$972K |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$246K | |
| 3 | -$157K | |
| 4 |
D.E. Shaw & Co
New York
|
-$46K |
| 5 |
Citigroup
New York
|
-$34.4K |